Hat mitgewirkt an:
-
A safe and potentiated multi-type HPV L2-E7 nanoparticle vaccine with combined prophylactic and therapeutic activity
-
Development of prophylactic and therapeutic combined vaccines against human papillomaviruses (HPV) using a multimerized thioredoxin (Trx) scaffold
-
A broadly protective vaccine against cutaneous human papillomaviruses
-
Inter-epitope spacer variation within polytopic L2-based human papillomavirus antigens affects immunogenicity